Robot-assisted surgery for right colon cancer
Official title: A Single Center Prospective Study Comparing Robot-assisted and Open Operation With Complete Mesocolic Excision (CME) in Extended Right Colectomy for Colon Cancer in the Right Flexure and Transverse Colon
Run by Vejle Hospital · NCT04190589 · Data updated 2026-11-12
This study is testing if robot-assisted surgery for right colon cancer can provide the same quality results as traditional surgery while helping patients recover faster and spend less time in the hospital.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 40 (estimated) |
| Sponsor | Vejle Hospital Academic / other |
| Locations | 1 site (Vejle) |
| Status | Recruiting |
| Started | May 18, 2020 |
| Main results expected | December 2026 |
| Study ends | December 2026 |
| Registry record updated | January 7, 2026 |
| Trial ID | NCT04190589 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older with UICC stage I-III colorectal cancer located in the specified areas.
✕Probably not a fit
Patients with a history of major open abdominal surgery, acute abdominal conditions, or high preoperative risk scores may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the effectiveness of extended robot-assisted right colectomy (e-RARC) compared to traditional extended open right colectomy (e-ORC) for patients with colorectal cancer located near the right flexure or the oral part of the transverse colon. It aims to assess whether the robotic approach can achieve similar specimen quality while reducing postoperative complications and length of hospital stay. A total of 40 patients undergoing e-RARC will be compared with 44 patients who previously underwent e-ORC. The study focuses on patients who are not the most technically demanding or frail, ensuring a more controlled comparison between the two surgical methods.
Why it matters
Potential benefit: If successful, this approach could lead to improved surgical outcomes and reduced recovery times for patients with right-sided colorectal cancer.
How similar studies have gone: While robotic surgery has shown promise in various surgical fields, this specific comparison of e-RARC to e-ORC is relatively novel and has not been extensively tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Suspected or verified colonic cancer visualized by colonoscopy and on CT in the anal part of the ascending colon, in the right flexure or in the oral 2/3 of the transverse colon * Patient is 18 years or older, legally competent and able to comprehend information and give consent * Tumor is UICC stage I-III on preop CT * Operation is elective Exclusion Criteria: * Previous major open intraabdominal surgery * Ileus or other acute abdominal condition * CT scan with suspicion of T4 tumor * RITA score \> 3 (Preop risk and frailty score) * BMI \> 35 kg/m2 * Project surgeon not available
Where it's running
-
Vejle Hospital, Department of Surgery
Vejle, Denmark Recruiting
Study contacts
- Principal investigator: Lars Bundgaard, MD — Department of Surgery
- Study coordinator: Hans B Rahr, MD DMSc
- Email: hans.rahr@rsyd.dk
- Phone: +4520574529
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Knife-assisted full-thickness resection for rectal lesions in a multicenter setting
A multicenter study tests knife-assisted full-thickness resection (kFTR) to remove rectal lesions in adults and see how well it works and how safe it is.
-
Personalized 3D Bioprinted Colorectal Cancer Microenvironment Model
This study tests patient-derived, 3D-bioprinted cancer models that include tumor, fibroblast, and immune cells to see if they can better predict how colorectal cancer will respond to treatment.
-
Integrated genomic and clinical database for cancer biomarker discovery
Researchers are building a combined genomic and clinical database at Samsung Medical Center to test biomarkers for cancer diagnosis, treatment choice, and predicting how well treatments work.
-
Prehabilitation with Resistance, Aerobic, or Both Before Colorectal Surgery
Four pre-surgery exercise options (resistance, aerobic, both, or none) will be tested to see which best reduces complications after colorectal cancer surgery.
-
Liver transplantation for colorectal cancer with liver metastases
This study follows adults with stage IV colorectal cancer whose disease is limited to the liver and who are getting a liver transplant as part of their cancer care to see how they fare over time.
-
LTZ-232: a first-in-human test in advanced colorectal and other solid tumors
A first-in-human study tests LTZ-232, a new therapy for adults with unresectable or metastatic colorectal cancer and other solid tumors that have not responded to standard treatments.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.